Skip to main content
logo
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.50
-0.42 (-3.85%)
At close: Jul 17, 2026, 4:00 PM EDT
10.71
+0.21 (2.00%)
After-hours: Jul 17, 2026, 5:09 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $422.00K in the quarter ending March 31, 2026, with 197.18% growth. This brings the company's revenue in the last twelve months to $839.00K, down -96.97% year-over-year. In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%.

Revenue (ttm)
$839.00K
Revenue Growth
-96.97%
P/S Ratio
591.13
Revenue / Employee
$9,534
Employees
88
Market Cap
495.96M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.87M29.01%
Dec 31, 202116.79M9.29M124.07%
Dec 31, 20207.49M7.17M2,215.11%
Dec 31, 2019323.57K--
Dec 31, 2018---
Dec 31, 201721.62K-928.69K-97.72%
Dec 31, 2016950.31K--
Dec 31, 2015---
Dec 31, 201423.37K-170.40K-87.94%
Dec 31, 2013193.77K-70.63K-26.71%
Dec 31, 2012264.40K-812.57K-75.45%
Dec 31, 20111.08M-2.61M-70.75%
Dec 31, 20103.68M893.28K32.03%
Dec 31, 20092.79M-435.52K-13.51%
Dec 31, 20083.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ginkgo Bioworks Holdings151.40M
Arvinas89.40M
Assembly Biosciences71.10M
Verastem49.59M
Crescent Biopharma11.88M
Shattuck Labs1.00M
ProKidney889.00K
Altimmune36.00K
Revenue Rankings

SLN News

More News